Elias Jatem Escalante

González, J; Jatem, E; del Carpio, J; Castañeda, ZI; Abó, AI; Martín, ML; Segarra, A

Epidemiological, clinical and prognostic issues in SARS-CoV-2 infection or vaccination-related glomerular disease: Our single-center experience

Nefrologia 44 582-583. 01/07/2024.

[doi:10.1016/j.nefro.2023.10.006]

Gonzalez J; Jatem E; Roig J; Valtierra N; Ostos E; Abo A; Santacana M; Garcia A; Segarra A

Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.

NEPHROLOGY DIALYSIS TRANSPLANTATION 37 2102-2110. 19/10/2022.

Roca, Neus; Jatem, Elias; Abo, Anabel; Santacana, Maria; Cruz, Alejandro; Madrid, Alvaro; Fraga, Gloria; Martin, Marisa; Gonzalez, Jorge; Martinez, Cristina; Balius, Anna; Segarra, Alfons

CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome.

CLINICAL KIDNEY JOURNAL 15 545-552. 01/03/2022.

[doi:10.1093/ckj/sfab215]

Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A

Quality of Life in Long-Term Renal Transplant Patients: A Controversial Subject

TRANSPLANTATION PROCEEDINGS 54 91-93. 01/02/2022.

[doi:10.1016/j.transproceed.2021.11.025]

Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A

Cost of Traveling to Follow-up Appointments at Kidney Transplant Clinics

TRANSPLANTATION PROCEEDINGS 54 94-95. 01/02/2022.

[doi:10.1016/j.transproceed.2021.11.005]

Medrano AS; Muijsemberg A; Wimbury D; Martin M; Jatem E; González J; Colás-Campás L; García-Carrasco A; Martínez C; Barratt J

Relationship between IgA1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in IgA nephropathy.

NEPHROLOGY DIALYSIS TRANSPLANTATION 37 318-325. 25/01/2022.

[doi:10.1093/ndt/gfaa356]

Jatem-Escalante, E; Martin-Conde, ML; Gracia-Lavedan, E; Benitez, ID; Gonzalez, J; Colas, L; Garcia-Carrasco, A; Martinez, C; Segarra-Medrano, A

Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy

CLINICAL KIDNEY JOURNAL 14 2556-2562. 01/12/2021.

[doi:10.1093/ckj/sfab116]

Del Carpio, J; Marco, MP; Martin, ML; Craver, L; Jatem, E; Gonzalez, J; Chang, P; Ibarz, M; Pico, S; Falcon, G; Canales, M; Huertas, E; Romero, I; Nieto, N; Segarra, A

External validation of the Madrid Acute Kidney Injury Prediction Score

CLINICAL KIDNEY JOURNAL 14 2377-2382. 01/11/2021.

[doi:10.1093/ckj/sfab068]

Roca N; Madrid A; Lopez M; Fraga G; Jatem E; Gonzalez J; Martinez C; Segarra A

Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes.

CLINICAL KIDNEY JOURNAL 14 1826-1834. 01/07/2021.

[doi:10.1093/ckj/sfaa265]

Roca N; Martinez C; Jatem E; Madrid A; Lopez M; Segarra A

Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.

CLINICAL KIDNEY JOURNAL 14 1207-1215. 01/04/2021.

[doi:10.1093/ckj/sfaa247]

Roca N; Jatem E; Martín ML; Muñoz M; Molina M; Martínez C; Segarra A

Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.

CLINICAL KIDNEY JOURNAL 14 543-549. 01/02/2021.

[doi:10.1093/ckj/sfz173]

Jatem, E; Lima, J; Montoro, B; Torres-Bondia, F; Segarra, A

Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome

Kidney International Reports 6 101-109. 01/01/2021.

[doi:10.1016/j.ekir.2020.09.046]

Groups

Publications